RXO: Barclays Raises Target
Barclays analyst Brandon Oglenski raises RXO price target to $28 and maintains Overweight rating
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.